Biosecurity and AI: Risks and Opportunities
AI-enabled biosecurity risk is an emerging governance gap - APS agencies working on AI risk frameworks or critical infrastructure should be aware of the threat landscape.
Key points
- AI could lower barriers to bioterrorism by coaching users through viral synthesis and attack planning.
- The analysis proposes targeted controls on AI biotech tools, DNA synthesis access, and sequence screening.
- APS-relevant as biosecurity intersects with AI governance, but this is a think-tank blog without direct Australian policy application.
Summary
The Centre for AI Safety outlines how advances in AI - particularly multimodal models and protein design tools - could meaningfully lower barriers to deliberate bioterrorism by assisting with viral synthesis, attack planning, and pathogen enhancement. The piece argues this risk is manageable without stifling legitimate research, recommending a layered approach: general pandemic resilience measures (ventilation, vaccines, surveillance), access controls on specialised AI biotech tools and DNA synthesis equipment, and behavioural monitoring of tool users. It frames biosecurity risk mitigation as complementary to AI-enabled medical progress rather than opposed to it.
Implications for Australian agencies
- Monitor Agencies involved in critical infrastructure protection or AI risk policy may want to monitor how biosecurity-AI intersections are addressed in emerging international AI governance frameworks.
- Consider APS AI governance practitioners could consider whether current AI risk assessment frameworks adequately account for dual-use biosecurity risks when evaluating AI tools in research or health contexts.
Implications are AI-generated. Starting points, not advice.
"Biosecurity and AI: Risks and Opportunities" Source: Centre for AI Safety – Blog Published: (undated) URL: https://safe.ai/blog/biosecurity-and-ai-risks-and-opportunities The Centre for AI Safety outlines how advances in AI - particularly multimodal models and protein design tools - could meaningfully lower barriers to deliberate bioterrorism by assisting with viral synthesis, attack planning, and pathogen enhancement. The piece argues this risk is manageable without stifling legitimate research, recommending a layered approach: general pandemic resilience measures (ventilation, vaccines, surveillance), access controls on specialised AI biotech tools and DNA synthesis equipment, and behavioural monitoring of tool users. It frames biosecurity risk mitigation as complementary to AI-enabled medical progress rather than opposed to it. Implications for Australian agencies: - [Monitor] Agencies involved in critical infrastructure protection or AI risk policy may want to monitor how biosecurity-AI intersections are addressed in emerging international AI governance frameworks. - [Consider] APS AI governance practitioners could consider whether current AI risk assessment frameworks adequately account for dual-use biosecurity risks when evaluating AI tools in research or health contexts. Retrieved from SIMS, 18 May 2026.